- Ensuring clinical success
- Tackling large scale regulatory challenges
- Finding the right framework for reimbursement and market access
- Cross-border healthcare
- Outcome based agreements
- Tackling large scale regulatory challenges
- Patient informed policy decisions
Conference
The Advanced Therapies Congress focuses on tackling challenges at each stage of development to accelerate development of next generation therapies to benefit patients. We bring together decision makers from key biotech and pharma companies, putting forward a good ratio of buyers and sellers in our audience.
With 8 tracks of content, the agenda covers everything from manufacturing, supply chain and logistics, pricing and market access, to developments in key therapeutic areas; cell therapy, gene therapy, gene modified cell therapy, gene editing, stem cells, regenerative medicine, and much more.
Topics
Evidence, Pricing & Access
Gene Modified Cell Therapy
- Autologous vs allogeneic
- Tackling solid tumours
- Combination therapy
- CAR-T, NK, Gamma-Delta cells
- Patient stratification and precision medicine approaches
Cell Therapy
- Stem cells
- Regenerative Medicine
- MSCs vs iPSCs
- Cord blood advancements
Gene Therapy
- Next generation of gene therapy
- Moving from rare to more common diseases
- Tackling immunogenicity
- Rare diseases & orphan drugs
- Novel gene delivery systems
- Gene editing
Cell Therapy Manufacturing
- Automation & closed systems
- Scaling up to commercial level
- Keeping costs low
- In house vs outsourcing
Viral Vector Manufacturing
- Continuous manufacturing
- Scaling up for commercial production
- In house vs outsourcing
Supply Chain & Logistics
- Logistics, transportation, distribution & cold chain
- Moving from clinical to commercial
- Patient experience
- Supply chain
- Point of care delivery
Innovation Showcase
- Latest in academic research
- Latest cutting-edge technologies success
Advisory Board
We have a core group of leading ATMP experts who help us put together the agenda each year. With their expertise we build a programme with the most informative and up to date content each year.
Susan Nichols
Chairwoman of the board
Rare Disease Innovations Institute
Chairwoman of the board
Rare Disease Innovations Institute
Apply to speak
Contact
c
hris.shanks@terrapinn.com
“High quality speakers, both in scientific/industrial content and the level of speaker sent in to speak - often CSO/CEO. I also appreciated the quality of the companies with stalls and the variation of startup companies to speak with”
Head of Development, Micregen
“It was a great event for anyone in ATMPs. ”
Managing Director, INDICRO Ltd
“Well organized, good turnout, talks of interest for people in the field, a good mix of service and solutions providers."
Chief Scientific Officer, Biointaxis S.L.
“Plenty of engaging talks, well laid out and easy to navigate both between talks and also to make your way through the stalls and displays. The terrapin app also works really well and I had many great conversations with stall holders.”
Cell Therapy Production Supervisor, Anthony Nolan
“Really interactive sessions, lot of commercial booths to discuss with product specialists, well structured talks organisation with focused sessions."
Senior Scientist, Orchard Therapeutics
“It was a great event. Was able to make good connections entrepreneurs, CROs, CDMOs and amazing scientist. Excellent mixture of startups, commercial and science.”
Executive Director, Aila Biotech
"Meeting remains a very nice forum to engage and exchange with our peers in CGT;. Great people and content and lots of opportunities to dialog with experts on our sector."
President and Chief Executive Officer, Co-Founder, NKILT Therapeutics Inc.
Get Involved with the Advanced Therapies Congress
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events